PAP Test - Cervical Smear Text

PAP Test - Cervical Smear Text

 

Pap Test

Home
Blog - What's New?
Abortion
Acne
Alternative Medicine
Amenorrhoea
Anatomy Female
Anorexia Nervosa
Bacterial Vaginosis
Birth Control
Birth Control Combined Pills
Bladder Symptoms
Breast Cancer
Breast Feeding
Cancer in Women
Candida - Thrush
Cervical Cancer
Childbirth
Chlamydia
Chronic Fatigue Syndrome
Constipation
Diet / Weight Loss
Down Syndrome Screening
Dysmenorrhoea
Ectopic Pregnancy
Endometrial Ablation
Endometrial Cancer
Endometriosis
Female Sexual Problems
Female Sterilization
Fibroids
Genital Herpes
Genital Warts
Gonorrhoea
Gynaecologist
Hirsutism
HIV / AIDS
HPV Human Papilloma Virus
HRT Preparations
HRT Risks & Benefits
Hysterectomy
Infertility
Infertility Anovulation
Infertility Male Factor
Infertility Tubal Factor
Infertility Unexplained
Intrauterine Device
In Vitro Fertilization IVF
Irritable Bowel Syndrome IBS
Libido - Sex Drive
Menopause
Menorrhagia Heavy Periods
Menstruation Menstrual Cycle
Miscarriage
Morning After Pill
Obesity
Ovarian Cancer
Ovarian Cysts
Painful Sex - Dyspareunia
Pap Test
PCOS
Pelvic Inflammatory Disease
Pelvic Pain
PMS- Premenstrual Syndrome
Pregnancy
Pregnancy & Childbirth
Progesterone Supplements
Prolapse
Seasonal Affective Disorder
Sex Education
Sexually Transmitted Disease
Syphilis
Teenage Pregnancy.
Ultrasound
Urinary Tract Infection - UTI
Urinary Incontinence
Vaginal Discharge
Illustrations
Search
The Author
Contact Us

  

 




In 1941, George Papanicolou identified cancer cells from the fluid aspirated from the upper vagina. The test has been modified to a PAP test (cervical smear) taken test under direct vision from the cervix (Figure 21.5). It was shown that malignant cells could be seen in the PAP test (cervical smear) test before the cervix became malignant, indicating that screening could lead to treatment and prevention (Figure 21.6).

Figure 21.5 Cervical Speculum

 

Figure 21.6 Falling Mortality Rates with Cervical Screening and Treatment



CERVICAL SCREENING
The benefits for women of liquid based cytology
Technological advances are making screening more accurate and less stressful for women. By Dr Anne Szarewski

EXPERT OPINON



Cervical cancer affects approximately 2,800 women in the UK each year, of whom roughly 1,000 die. The NHS screening programme was set up in 1988; since then, women have been invited for cervical screening at least once every five years between the ages of 20 and 64 in England and Wales and every three years between the ages of 20 and 60 in Scotland.
Cervical cancer is unusual in having a pre-invasive stage (cervical intraepithelial neoplasia, or CIN), which potentially makes it almost completely preventable by screening. In the UK, about 200,000 women each year have an abnormal cervical smear. Between 1987 and 1997, the mortality rate dropped by about 40 per cent; incidence has also fallen, from 16 women per 100,000 in 1986 to 9.6 per 100,000 in 2000. A recent paper estimated that screening saves about 4,500 lives every year.!

 

 

You are welcome to visit my shopping mall which supports this website.



LIQUID BASED CYTOLOGY
One of the main problems with the conventional smear is that up to 80 per cent of the cells collected are not transferred from the spatula to the slide. In addition, excessive blood and mucus lead to unsatisfactory smears, necessitating recall.
In October 2003, it was announced that liquid based cytology (LBC) would be introduced in England and Wales (Scotland already had it). The principle ofLBC is that instead of smearing the spatula across a slide, it is rinsed in a vial of preserving solution. A small plastic brush is used, because cells tend to stick to wooden implements. In the laboratory, the vial is agitated to distribute the cells evenly, then they are filtered out under pressure to produce a thin layer on a slide. One advantage of this is that the machine always takes the same number of cells.
The main advantage ofLBC is that it greatly reduces the number of inadequate smears; in the UK pilot study, the inadequate rate fell from 9.1 per cent with conventional cytology to 1.6 per cent with LBC.2 Anybody who deals with women in the screening programme knows that the anxiety caused by inadequate smears is enormous and if there were no other advantages to LBC, it would be worth introducing for this alone.
Another advantage is that thin layer cytology is easier to read because there are no clumps of cells and no blood or
mucus obscuring the view. Screening times in the laboratory are reduced, so throughput is increased and results are made available more quickly.
Studies have also suggested there may be a reduction in the number of borderline smears reported and greater detection of high-grade CIN. However, a recently published randomised trial conducted in Italy3 showed no increase in the sensitivity ofLBC compared with conventional cytology. There are conflicting results in different studies and it is likely that the level of staff training and quality assurance is important - it is difficult to show improvements where the standard is already very high. It is also apparent from the pilot studies that there is a learning curve for LBC. A cost analysis showed that the reduction in inadequate smears alone makes LBC cheaper in the long run than conventional cytology, although this does not take into account the considerable start-up costs.

COMPUTERISED SLIDE SCREENING
LBC makes it easier to introduce computerised slide screening, a major step forward. In this, a computer is fed numerous images of normal and abnormal smears and programmed to draw attention only to those fields it considers not completely normal.


Severe dyskaryosis: studies suggest that liquid based cytology can detect more high grade CIN than conventional methods

Research has shown that this technology holds great promise. The computer identifies 22 fields of interest most likely to have abnormal cells, which are then examined by a cytologist.
In the study, LBC slides obtained in a large population under routine clinical practice and read using the computerised system detected significantly more histological high-grade cervical disease than conventional cytology slides. A study based on the same cytologists showed that the mean time taken to evaluate and report LBC slides using the computerised system was 41 minutes per slide, compared to 10.6 minutes per slide for conventional cytology.
Another useful aspect of LBC is that the same sample can be used for other tests, for example, chlamydia, gonorrhoea and HPV. This opens up the possibility of 'reflex' HPV testing for triage - if a woman has a borderline smear, her LBC sample can be tested for HPV; without the need for another examination. If' the HPV test is negative, this would be reassuring, because it virtually rules out any possibility of disease. This was tried in some pilot sites, but a problem arose because HPV resting gives many false positives. This approach still needs some thought, but is another string to the bow of LBC..


Related Medical Abstracts - Click on the paper title:-


 

 


Back Home Next




Please click on the required question.